A detailed history of Inspire Advisors, LLC transactions in Deciphera Pharmaceuticals, Inc. stock. As of the latest transaction made, Inspire Advisors, LLC holds 12,577 shares of DCPH stock, worth $0. This represents 0.03% of its overall portfolio holdings.

Number of Shares
12,577
Previous 13,308 5.49%
Holding current value
$0
Previous $214,000 7.94%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$13.58 - $17.36 $9,926 - $12,690
-731 Reduced 5.49%
12,577 $197,000
Q4 2023

Feb 12, 2024

BUY
$10.11 - $16.54 $134,543 - $220,114
13,308 New
13,308 $214,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Inspire Advisors, LLC Portfolio

Follow Inspire Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Advisors, LLC with notifications on news.